Riemser Pharma
Riemser is a pan-European specialty pharma company that has strengths in the marketing and distribution of pharmaceuticals in niche areas of oncology, neurology, infectious diseases and other fields.
Since it was established in 1992, the Germany company has evolved from a manufacturer of veterinary medicines to a successful provider of specialty pharmaceuticals for therapeutic niches in the field of human medicine, and has chalked up more than 400 approvals worldwide.
Latest Riemser Pharma News & Features
23 April 2018
12 May 2014
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze